SCHEMBL19981535

SCHEMBL19981535

COP(C)(=O)N1CCC(NC(=O)c2cccc(-c3ccccc3)c2)CC1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.55
DRD4 P21917 3/20 0.55
USP30 Q70CQ3 2/20 0.53
ALDH1A1 P00352 2/20 0.50
NPC1 O15118 3/20 0.48
RAB9A P51151 2/20 0.48
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CTDSP1 Q9GZU7 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
TSHR P16473 1/20 0.47
MCHR1 Q99705 1/20 0.47
HTR7 P34969 2/20 0.46
PKM P14618 1/20 0.46
MAPK1 P28482 1/20 0.46
CYP2C19 P33261 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
HTR1A P08908 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19981405 0.89 ALDH1A1 (0.52) DRD4ALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL15443854 0.88 DRD2 (0.55) DRD2DRD4USP30ALDH1A1NPC1
SCHEMBL15871568 0.87 DRD2 (0.54) DRD2DRD4USP30ALDH1A1NPC1
SCHEMBL20019688 0.86 TAS1R3 (0.49) DRD2DRD4USP30ALDH1A1NPC1
SCHEMBL19981430 0.84 USP2 (0.45) ALDH1A1RAB9ATSHRMCHR1HTR7
SCHEMBL20019694 0.83 ABL1 (0.49) DRD2DRD4USP30RAB9AKMT2A
SCHEMBL16209894 0.82 DRD2 (0.61) DRD2DRD4USP30ALDH1A1NPC1
SCHEMBL14980322 0.82 DRD2 (0.63) DRD2DRD4USP30ALDH1A1NPC1
SCHEMBL14655021 0.79 ALDH1A1 (0.49) DRD4ALDH1A1RAB9ASMN1; SMN2TSHR
SCHEMBL28900449 0.79 DRD2 (0.60) DRD2DRD4USP30NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2788487-B1 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA SAREPTA THERAPEUTICS INC (US) 2018-04-04 EP disclosed
EP-2788488-B1 METHODS FOR TREATING PROGEROID LAMINOPATHIES USING OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA SAREPTA THERAPEUTICS INC (US) 2018-03-21 EP disclosed